Next-generation biotherapeutics utilize a novel biomolecules and delivery mechanisms to tackle disease. Grown in cell media, these therapeutics require a variety of chemical and physical characterization steps to ensure quality during manufacturing and promote basic understanding during development. From protein secondary structure analysis with Raman; to rapid infectious titer determination with simultaneous multi-laser NanoTracking Analysis; to AAV characterization and vaccine batch release with the A-TEEM fluorescence method, HORIBA provide answers that matter, providing insight into biotherapeutics, from development to manufacturing.

Browse Applications

Monitoring Biotinylated Adeno-Associated Virus (AAV) using A-TEEM
Monitoring Biotinylated Adeno-Associated Virus (AAV) using A-TEEM
Adeno-Associated Viruses (AAVs) are becoming widely used as viral vectors to deliver cell and gene therapies and vaccines. As production methods scale to meet growing demand, more information is needed more quickly.

 ↑ Back to Top